Angewandte Chemie International EditionBiochemistryPeer-reviewed journal article
The endogenous metabolite hypochlorite activates indoleamine 2,3-dioxygenase-1 for catalysis: Functional and mechanistic implications
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 41%
Abstract
Indolamine 2,3-dioxygenase (IDO1) is a hemoprotein that catalyzes the oxidative cleavage of L-tryptophan (L-Trp) to N-formyl-L-kynurenine (L-NFK) along the kynurenine pathway. Its activity depletes L-Trp while initiating a signaling cascade culminating in an immunosuppressive outcome of clinical significance. The generally used in vitro activity assay for IDO1 relies on ascorbic acid and synthetic methylene blue, with the endogenous activator still uncertain. Here we demonstrate sodium hypochlorite, commonly known as bleach, functions as an in vitro activator/cofactor for the recombinant human IDO1-catalyzed dioxygenation reaction. Other hypohalous acids, generated in situ by lactoperoxidase (LPO) or in aqueous solutions of I2 or Br2, also activate IDO1. Contrastingly, the pseudohalide thoicyanate, a known, excellent substrate for LPO, yielded only trace levels of L-NFK. Importantly, complete conversion to L-NFK occurs with sub-stoichiometric hypohalous acid relative to L-Trp, and the overall reaction remains O2-dependent. Kinetic analysis with variable L-Trp and multiple, fixed concentrations of the activators/ cofactors revealed typical Michaelis-Menten kinetics without substrate inhibition, which contrasts past analysis using alternative IDO1 assays. The calculated second order rate constants were overall comparable regardless of the identity and concentration of hypohalous acid. Finally, 1-methyl-L-tryptophan, a reported inhibitor and poor substrate for rhIDO1, was reexamined with the hypohalous acid-dependent conditions revealing an improved catalytic efficiency when compared with the native substrate L-Trp. Along with this unanticipated result, the in vivo functional and mechanistic implications of the newly discovered hypohalous acid-dependent IDO1 activity are discussed. SignificanceIndoleamine 2,3-dioxygenase-1 (IDO1) is a hemoprotein that catalyzes the conversion of L-tryptophan to N-formyl-L-kynurenine (L-NFK). Past efforts have culminated in the conclusion that IDO1 is a checkpoint modulator of mammalian immunity, both in terms of the immunogenicity and immune tolerance. However, the identity of the endogenous activator of IDO1 is still unsettled. Here we report that sodium hypochlorite, aka bleach, activates ferric rhIDO1 in a catalytic manner, enabling rhIDO1 to efficiently catalyze the production of L-NFK in an O2-dependent reaction. The results suggest rhIDO1 can efficiently operate via a hypochlorous acid-dependent mechanism that is reminiscent of the peroxide-shunt pathway used by other hemoproteins. Furthermore, the results suggest a functional role for endogenously produced hypochlorous acid beyond solely killing foreign pathogens.
- organism: human
- assay: proteomics
- research focus: protein folding & dynamics
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of apo-form selective inhibition of indoleamine 2,3-dioxygenase.
R. F. Ortiz-Meoz, L. Wang, … G. Zhang·bioRxiv·May 7, 2020
- Indoleamine Dioxygenase and Tryptophan Dioxygenase Activities are Regulated through Control of Cell Heme Allocation by Nitric Oxide
P. Biswas, D. J. Stuehr·bioRxiv·Dec 30, 2022
- Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes
M. Solvay, P. Pfander, … J. Zhu·bioRxiv·Jan 16, 2023
- Discovery and binding mode of small molecule inhibitors of the apo form of human TDO2
C. Lotz-Jenne, R. Lange, … A. Mac Sweeney·Scientific ReportsPeer-reviewed·Nov 14, 2024
- 3-hydroxykynurenine is a ROS-inducing cytotoxic tryptophan metabolite that disrupts the TCA cycle
J. L. Buchanan, A. Rauckhorst, E. B. Taylor·bioRxiv·Jul 10, 2023
- Monovalent Pseudo-Natural Product Degraders Supercharge the Native Degradation of IDO1 by KLHDC3
Elisabeth Hennes, Belén Lucas, … Herbert Waldmann·Nature ChemistryPeer-reviewed·Jan 7, 2026